| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $587.7M | $581.0M | $587.4M |
| YoY Revenue Growth % | +1.1% | -1.1% | — |
| Gross Profit | $143.9M | $126.7M | — |
| Gross Margin % | 24.5% | 21.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $20.7M | -$6.3M | -$20.1M |
| Operating Margin % | 3.5% | -1.1% | -3.4% |
| Net Income (GAAP) | -$32.8M | -$72.9M | -$75.8M |
| EBITDA (Normalized) | $34.2M | $2.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$68.9M | -$118.7M | -$42.3M |
| Capital Expenditures (CapEx) | $16.8M | $11.2M | — |
| Free Cash Flow (FCF) | -$85.7M | -$129.9M | -$42.3M |
| FCF Margin % | -14.6% | -22.4% | -7.2% |
| Return on Invested Capital (ROIC %) | 95.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $89.5M | $26.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$131.5M | -$283.8M | — |